News
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
The FDA previously granted breakthrough therapy designation to ziftomenib for relapsed/refractory NPM1-mutant AML.
The nonprofit Physicians Committee for Responsible Medicine, which promotes the use of human-relevant test methods to replace ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and ...
This blog delves into the rise of rare disease drug approvals and the critical importance of regulatory guidance in shaping ...
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
Thursday’s FDA announcement said that “the new approach is designed ... data in support of their application. “This initiative marks a paradigm shift in drug evaluation and holds promise ...
2d
Health and Me on MSNFDA Plans To Halt Animal Testing For Drug Approval, What Could Replace It?In other news, the US Food and Drug Administration is now reducing animal testing for drug development and will replace it ...
2d
Tampa Free Press on MSNFDA Announces Groundbreaking Shift: Replacing Animal Testing With Advanced Human-Relevant Methods For Drug DevelopmentIn a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results